Intriguingly, Kanel et al. (2020) performed PET with [18F]-fluoroethoxybenzovesamicol ([18F]-FEOBV), a radioligand for vesicular acetylcholine transporter (VAChT), in patients with DLB to determine cholinergic vulnerability topography. Here, SLC18A3 is linked to Lewy body dementia.